FDA Inspection 1311070 — Cerveau Technologies, Inc.
The FDA completed an inspection of Cerveau Technologies, Inc. on Mar 26, 2026 in Bedford, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 26, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bedford, MA (United States)
Additional details
Sponsor, Contract Research Organization